Metraipolis › archive › dc_cb906eb80d67
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial — Europe PMC PMID:41837971
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41837971
- DOI
- 10.1001/jamainternmed.2026.0057
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T22:25:32.060Z
- SHA-256 of the archived text
5d64bed2d8c25454d5a484bee56e1a06ad40b88c27817385e77676c4ff28d43e- Stable URL of this page
https://metraipolis.com/documento/dc_cb906eb80d67
How to cite
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial — Europe PMC PMID:41837971 — Europe PMC (en), https://europepmc.org/article/MED/41837971 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb906eb80d67 (Metraipolis archive dc_cb906eb80d67, sha256 5d64bed2d8c25454d5a484bee56e1a06ad40b88c27817385e77676c4ff28d43e)
BibTeX
@misc{dccb906eb80d67,
title = {Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial — Europe PMC PMID:41837971},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41837971},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb906eb80d67; sha256 5d64bed2d8c25454d5a484bee56e1a06ad40b88c27817385e77676c4ff28d43e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41837971. Agents can read the archived copy with the MCP tool read_document.